Aprea Therapeutics Q1 EPS $(0.36) Up From $(0.46) YoY

Aprea Therapeutics (NASDAQ:APRE) reported quarterly losses of $(0.36) per share. This is a 21.74 percent increase over losses of $(0.46) per share from the same period last year.